24/7 Newsfeed

Put Reason 24/7 on Your Site


Follow Reason 24/7 on Twitter and via RSS

Canada Blocks Lung Infection Drug from Dying Patients

Two lung disease specialists are accusing Health Canada of shortening some patients' lives, by denying them access to an inexpensive, relatively harmless drug not sold in Canada.

“I am appalled and angry that a federal agency that we fund through our taxes would deny Canadian citizens who are dying of a treatable, infectious disease potentially life-saving medication,” said Dr. David Forrest, of Nanaimo, B.C.

In previous years, Health Canada granted several patients special access to the drug, called clofazimine. The doctors said that approach has suddenly changed, for no good reason.

“We had a process in place that was working, for 20 years or so, and now all of a sudden we’re running up against a brick wall,” said Dr. Stephen Field, from Calgary.

(Hat tip to Reason commenter RTS)

Source: CBC News. Read full article. (link)

Editor's Note: We invite comments and request that they be civil and on-topic. We do not moderate or assume any responsibility for comments, which are owned by the readers who post them. Comments do not represent the views of Reason.com or Reason Foundation. We reserve the right to delete any comment for any reason at any time. Report abuses.

  • Sevo||

    We NEED governments to manage our medical care, since we're not smart enough to do it on our own...

  • JeremyR||

    But you can't get it in the US either...

    "Clofazimine is widely available in developing countries, but is not approved for sale in the U.S. or Canada, because the drug company Novartis hasn’t applied for approval."

  • JeremyR||

    And the reason the company hasn't, because it won't make enough money for them.

  • JeremyR||

    To be fair you apparently can't use it in the US, either.